Automotive Differential Gear Market size is set to grow by USD 5.64 billion from 2024-2028, Increase in sales of SUVs boost the market, Technavio
NEW YORK, July 26, 2024 /PRNewswire/ — The global automotive differential gear market size is estimated to grow by USD 5.64 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.36% during the forecast period. increase in sales of SUVs is driving ma
Polymer Binder Market size is set to grow by USD 12.61 billion from 2024-2028, Growth in textile industry to boost the market growth, Technavio
NEW YORK, July 26, 2024 /PRNewswire/ — The global polymer binder market size is estimated to grow by USD 12.61 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.51% during the forecast period. Growth in textile industry is driving market growth,
Automatic Pill Dispensing Systems Market size is set to grow by USD 2.15 billion from 2024-2028, Growing aging population boost the market, Technavio
NEW YORK, July 26, 2024 /PRNewswire/ — The global automatic pill dispensing systems market size is estimated to grow by USD 2.15 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 9.45% during the forecast period. Growing aging population is driving
Salts And Flavored Salts Market size is set to grow by USD 11.30 billion from 2024-2028, Strategies adopted by leading players boost the market, Technavio
NEW YORK, July 26, 2024 /PRNewswire/ — The global salts and flavored salts market size is estimated to grow by USD 11.30 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.09% during the forecast period. Strategies adopted by leading players is dr
Innocan Pharma Submits Investigational New Animal Drug Application to FDA’s Veterinary Center
HERZLIYA, Israel and CALGARY, AB, July 26, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA’s Cente
Anterix to Release First-Quarter Earnings for Fiscal 2025, Hold Analyst and Investor Call
WOODLAND PARK, N.J., July 26, 2024 /PRNewswire/ — Anterix (NASDAQ: ATEX) announced today that it will release its first quarter financial results for the 2025 fiscal year after the close of the market on Tuesday, August 6, 2024. Anterix senior management will hold an analyst and investor confe
Fox Corporation Executives to Discuss Fourth Quarter and Full Year Fiscal 2024 Financial Results Via Webcast
NEW YORK and LOS ANGELES, July 26, 2024 /PRNewswire/ — Fox Corporation (Nasdaq: FOXA, FOX) will discuss fourth quarter and full year financial results for the 2024 fiscal year ended June 30, 2024, via a live audio webcast beginning at 8:00 a.m. ET / 5:00 a.m. PT on August 6, 2024. Results wil
Civista Bancshares, Inc. Declares Third Quarter Common Dividend
SANDUSKY, Ohio, July 26, 2024 /PRNewswire/ — Civista Bancshares, Inc. (NASDAQ:CIVB) (“Civista”) announced today that the Board of Directors has approved a quarterly dividend of 16 cents per common share to shareholders of record August 6, 2024, payable August 20, 2024. This divi
K1 Issues MariaDB Compulsory Acquisition Notices
MANHATTAN BEACH, Calif., July 26, 2024 /PRNewswire/ — Meridian BidCo LLC (“Bidco”), an affiliate of K1 Investment Management, LLC (“K1”), announced earlier this week that its tender offer to acquire the entire issued and to be issued share capital of MariaDB plc (“
FDA Roundup: July 26, 2024
SILVER SPRING, Md., July 26, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to include initiation of treatment, up-dosing
